[go: up one dir, main page]

ATE267867T1 - Chimäre serinproteasen - Google Patents

Chimäre serinproteasen

Info

Publication number
ATE267867T1
ATE267867T1 AT98122481T AT98122481T ATE267867T1 AT E267867 T1 ATE267867 T1 AT E267867T1 AT 98122481 T AT98122481 T AT 98122481T AT 98122481 T AT98122481 T AT 98122481T AT E267867 T1 ATE267867 T1 AT E267867T1
Authority
AT
Austria
Prior art keywords
domain
serine proteases
chimeric
serine protease
chimeric serine
Prior art date
Application number
AT98122481T
Other languages
English (en)
Inventor
Wolfram Bode
Richard Engh
Karl-Peter Hopfner
Robert Huber
Erhard Kopetzki
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE267867T1 publication Critical patent/ATE267867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6467—Granzymes, e.g. granzyme A (3.4.21.78); granzyme B (3.4.21.79)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Facsimile Transmission Control (AREA)
AT98122481T 1997-12-03 1998-11-27 Chimäre serinproteasen ATE267867T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97121232 1997-12-03

Publications (1)

Publication Number Publication Date
ATE267867T1 true ATE267867T1 (de) 2004-06-15

Family

ID=8227728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98122481T ATE267867T1 (de) 1997-12-03 1998-11-27 Chimäre serinproteasen

Country Status (6)

Country Link
US (3) US6159722A (de)
JP (1) JP3087746B2 (de)
AT (1) ATE267867T1 (de)
AU (1) AU708674B2 (de)
CA (1) CA2254647C (de)
DE (1) DE59811465D1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818418B1 (en) * 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US7115396B2 (en) * 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
DK1399568T3 (da) * 2001-02-01 2006-03-27 Hoffmann La Roche Fremgangsmåde til fremstilling af rekombinant trypsin
US6638503B2 (en) * 2001-11-28 2003-10-28 Maharashtra Association For The Cultivation Of Science Streptomyces megasporus sd5, process for the isolation thereof, novel fibrinolytic enzyme prepared therefrom, process for the production of said enzyme and method of treatment of thrombolytic disorders using said enzyme
US20050074865A1 (en) * 2002-08-27 2005-04-07 Compound Therapeutics, Inc. Adzymes and uses thereof
US20040081648A1 (en) * 2002-08-27 2004-04-29 Afeyan Noubar B. Adzymes and uses thereof
BRPI0417302A (pt) 2003-12-05 2007-03-06 Compound Therapeutics Inc inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
US20080220049A1 (en) * 2003-12-05 2008-09-11 Adnexus, A Bristol-Myers Squibb R&D Company Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
JP2008505119A (ja) * 2004-06-30 2008-02-21 ネクター セラピューティクス アラバマ，コーポレイション 高分子−第ｉｘ因子部分の抱合体
MX2009005466A (es) 2006-11-22 2009-08-17 Adnexus A Bristol Myers Sqibb Terapeuticos dirigidos a base de proteinas manipuladas para receptores de tirosina cinasas, incluyendo receptor de factor de crecimiento tipo insulina-i.
CN102007145A (zh) 2008-02-14 2011-04-06 百时美施贵宝公司 基于结合egfr的工程化蛋白质的靶向治疗剂
CN102099373A (zh) 2008-05-22 2011-06-15 百时美施贵宝公司 基于纤连蛋白的多价支架结构域蛋白
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
EP2501714A4 (de) * 2009-11-17 2015-10-07 Univ Montreal Heteropeptide zur reduzierung nichtspezifischer adsorption
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
CN103180339B (zh) 2010-05-26 2016-04-27 百时美施贵宝公司 具有改善的稳定性的基于纤连蛋白的支架蛋白质
MX365612B (es) 2012-07-25 2019-06-07 Catalyst Biosciences Inc Polipeptidos de factor x modificados y usos de los mismos.
EP3129401B1 (de) 2014-03-20 2019-06-12 Bristol-Myers Squibb Company Serumalbuminbindende fibronectin-typ-iii-domänen
WO2017053617A1 (en) 2015-09-23 2017-03-30 Bristol-Myers Squibb Company Fast-off rate serum albumin binding fibronectin type iii domains

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US5304631A (en) * 1990-01-16 1994-04-19 University Of Colorado Foundation, Inc. Synthetic helizyme enzymes
ATE135044T1 (de) * 1990-01-25 1996-03-15 Univ Washington Faktor x-laci-hybridprotein
IL134653A0 (en) * 1997-08-22 2001-04-30 Roche Diagnostics Gmbh Zymogenic protease precursors that can be autocatalytically activated and their use
AU9341398A (en) * 1997-08-22 1999-03-16 Boehringer Mannheim Gmbh Protease precursors that can be autocatalytically activated and their use

Also Published As

Publication number Publication date
AU9605898A (en) 1999-06-24
JPH11235173A (ja) 1999-08-31
AU708674B2 (en) 1999-08-12
CA2254647A1 (en) 1999-06-03
CA2254647C (en) 2002-07-16
US6660492B1 (en) 2003-12-09
JP3087746B2 (ja) 2000-09-11
US6159722A (en) 2000-12-12
DE59811465D1 (de) 2004-07-01
US6171842B1 (en) 2001-01-09

Similar Documents

Publication Publication Date Title
DE59811465D1 (de) Chimäre Serinproteasen
ES2180024T3 (es) Radio telefono.
HN1995009160A (es) Derivados de cicloalcano indol y azaindol
DK0753057T3 (da) Alkalisk Bacillus-amylase
BR9507237A (pt) Protease altamente alcalina e sua aplicação
ATE250669T1 (de) Proteolytische enzyme und ihre verwendung in waschmitteln
NO306458B1 (no) DP-IV-serin proteaseinhibitorer
PT717778E (pt) Serina proteases resistentes a alcalinidade elevada
NO20051274L (no) Kledningsplate
DK1135300T4 (da) Dåseende med lille diameter og stor åbning
TR200001878T2 (tr) Hilal şekilli dudakları olan gaga-tipi valf.
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
ATE259512T1 (de) Tragbares telefon und einschaltverfahren
NO20011966D0 (no) Serin-protease-inhibitor
BR0116166A (pt) Inibidores da serina protease
ATE153670T1 (de) Peptidboronsäurederivate mit protease inhibierenden aktivität
ATE479420T1 (de) Orale zusammensetzung mit verbesserten mundhygieneeigenschaften
ES2065695T3 (es) Proteasa termoestable de thermococcus.
DE60116474D1 (de) Hcv ns2/3 fragmente und ihre verwendungen
SE0004850D0 (sv) Shield can
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması
ATE349267T1 (de) Abstandselement
DE69129785D1 (de) Monolithisch integrierbarer Schalter mit niedrigem Leistungsverbrauch für Fernsprechapparate und dergleichen
ES2113761T3 (es) Peroxido de benzoilo desactivado provisionalmente, procedimiento para su preparacion y su utilizacion.
PT1119351E (pt) Utilizacao de derivados de catecol como inibidores de proteinases

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee